Bristol-Myers Squibb Company (BMY) SEC filings
Bristol-Myers Squibb Company (BMY) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported BMY revenue for 2026-03-31 was $11.49B. Net income was $2.68B. Revenue was down 76.2% from 2025-12-31 to 2026-03-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5. The BMY filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Bristol-Myers Squibb Company said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
0
8-K
0
Form 4
No cached SEC filings for BMY yet. When an 8-K lands, this page will show the exhibit headline and numbers.
Open EDGAREDGAR is the official archive. Browse all BMY filings.
Frequently asked questions
What did BMY just say?
BMY cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are BMY SEC filings?
0 cached filings are on this page. EDGAR remains the official archive.
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.